Redefining
Breast Cancer Treatment
The only image-guided prone LINAC
designed exclusively for breast cancer radiotherapy
Built for Her.
Breast cancer treatment should be designed around the woman receiving it. MammoKnife was purpose-built to deliver precise radiotherapy with her comfort, experience, and care in mind.
The standard isn’t the standard anymore
No vault, bunker, or major construction required
Rethinking
how and where
breast radiotherapy
can be delivered
MammoKnife Supports:
-
Supports improved patient outcomes and tissue preservation
Radiobiological & Clinical Benefits
Distributed entrance and exit dose avoid hot spots to non-target breast tissue
Reduced acute radiation dermatitis
Reduced long-term fibrosis and improved cosmetic outcomes
-
Allows for installation in standard clinical environments or any health center setting.
No vault required, increasing access and reducing facility cost and complexity for costly bunkers
-
Engineered to deliver unparalleled precision and dose conformity across whole-breast radiotherapy, with or without boost, accelerated partial breast radiotherapy, and stereotactic ablative radiotherapy.
No vault, bunker, or major construction required
The MAMMOKNIFE is a dedicated breast radiotherapy platform designed to improve clinical precision, patient comfort, and treatment workflow. Its self-shielded, compact design allows installation in standard clinical environments.
By treating patients in the prone position, MAMMOKNIFE isolates the breast from surrounding organs and reduces radiation exposure to the heart and lungs supporting improved outcomes and patient safety while enabling a more comfortable treatment experience.
Stereotactic surgery intended to support whole-breast radiotherapy, with or without boost, as well as accelerated partial breast radiotherapy or stereotactic ablative radiotherapy.
How MAMMOKNIFE works
Rotational 6MV LINAC
The system combines high-quality image guidance within a shielded environment to ensure precise radiotherapy delivery.
Reduced Skin Toxicity
The patient is positioned prone with the breast falling through the table, allowing the treatment beam to travel parallel to the chest wall.
Self-Shielded
Only the breast is exposed within the radiation field, avoiding dose to the heart, lungs, and surrounding structures.
270° LINAC rotation around the breast tissue only
Currently in development. MAMMOKNIFE has not been cleared or approved by the U.S. Food and Drug Administration (FDA) and is not available for commercial use.
Developed in partnership with
